Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
- Product Sales of $90 Million to $120 Million Expected in 2008
- Initial Results from JZP-6 Phase III Clinical Trial Expected by Year End
- New Data Provided on Pipeline and Early-Stage Development Portfolio - 2008 Financial Guidance Provided
PALO ALTO, Calif., March...
Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
... and sales volume growth. Net sales of once-daily luvox
CR(R) (fluvoxamine maleate) Extended Release Capsu...quarter of 2009 reflects a decrease in spending on luvox
CR and the 2008 reductions in force.
Jazz Pha... $17,719 $11,341
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
...r ended December 31, 2007. Net sales of once-daily luvox
CR(R) (fluvoxamine maleate) Extended-Release Capsu... spending in connection with launch activities for luvox
CR, including increased headcount and higher expen...quarter of 2008 reflects a decrease in spending on luvox
CR and reductions in headcount.
FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Administration (FDA) has approved Once-A-Day luvox
CR (fluvoxamine maleate)
Extended-Release Capsules...and obsessive compulsive disorder (OCD) in adults. luvox
CR is a
selective serotonin reuptake inhibitor (SS...curately diagnosed."
"The approval of Once-A-Day luvox
CR (fluvoxamine maleate)
Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
...Jazz Pharmaceuticals continues to expect to launch luvox
CR in the United
States during the first quarter o...ise any questions related to safety or
efficacy of luvox
CR and included the FDA's proposed labeling.
The NDA for luvox
CR seeks marketing approval for the treatment of
Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
... ramps up for the anticipated commercial
launch of luvox
CR in early 2008, we have also made progress in al...ce in preparation for the commercial launch of luvox
CR began in August 2007, with more than 100 ne...as of October 31, 2007. The PDUFA action date for luvox
CR is December 22, 2007. The company expects ...
Benefits of Antidepressants to Pregnant Women Outweigh Risks to the Fetus
...ous complications at birth. The department a list of drugs, Wellbutrin (bupropion); Celexa (citalopram); Cipralex (escitalopram); Prozac (fluoxetine); luvox
(fluvoxamine); Remeron (mirtazapine); Paxil (paroxetine); Zoloft (sertraline), Effexor (venlafaxine) and Zyban (bupropion).
Luvox in Biological Technology
Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering
...ts related to the anticipated closing of the
offering, commercial launch of luvox
CR, the continued development of Jazz
Pharmaceuticals' JZP-6 product candid...ering will close when anticipated or at
all; risks related to the launch of luvox
CR; risks related to the
development of Jazz Pharmaceuticals' product candi...
Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
...illion for the
first quarter of 2007.
CR(R) (fluvoxamine maleate) Extended-Release Capsu...salers
late in the first quarter.
"The launch of luvox
CR in the U.S. is progressing very well," said
Rob...y due to spending in preparation for the
launch of luvox
CR, increased headcount and higher expenses to sup...
Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
...r lenders very quickly after the FDA's
approval of luvox
CR, together with obtaining an option for addition...ine maleate) Extended-Release Capsules, to
CR launch expenses, and for general corporate purp...ebt by an additional $30
million and the launch of luvox
CR. Words and phrases such as "will,"
"plan," "is ...
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
...ded Phase III clinical trial activities for
CR scale-up and manufacturing costs and increased ...eparation for the anticipated
launch of Once-A-Day luvox
CR (fluvoxamine maleate) Extended-Release
Capsules...uticals, Inc. to the FDA approvable letter for luvox
CR. The FDA notified Solvay Pharmaceuticals that ...
FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
...ease visit http://www.JazzPharmaceuticals.com .
is a registered trademark of Solvay Pharmaceutical...d to the implications of the approvable
letter for luvox
CR. These forward-looking statements inherently in...which include, without limitation, whether or when luvox
will be approved or launched. These and other r...
Luvox in Biological Definition
Selective serotonin reuptake inhibitor
...lex ® )
Citalopram (trade name: Celexa ® , Cipramil ® , Emocal ® , Sepram ® )
Fluvoxamine maleate (trade name: luvox
® , Faverin ® )
Paroxetine (trade name: Paxil ® , Seroxat ® , Aropax ® )
How they work
In the brain , info...